JRCT ID: jRCT1030240292
Registered date:22/08/2024
Voicing Out Candid thoughts and Ascertaining LImitations on conveying Zest and Emotions in decision-making of patients with advanced renal cell carcinoma VOCALIZE Study
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | advanced renal cell carcinoma |
Date of first enrollment | 22/08/2024 |
Target sample size | 200 |
Countries of recruitment | |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Psychological and Environmental factors making patients leave treatment decisions to physicians without expressing their preferences. Environmental factors encouraging patients to express their treatment preferences to physicians. |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 18age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | Patients diagnosed with advanced renal cell carcinoma who have received first-line treatment |
Exclude criteria | Patients who are engaged in pharmaceutical, medical, or market research related occupations |
Related Information
Primary Sponsor | Kenya Ochi |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Takano Naoyuki |
Address | 13-23, minami 1-Chome ikebukuro toshima-ku,Tokyo Tokyo Japan 171-0022 |
Telephone | +81-120-974-268 |
info_oncolo@3h-ct.co.jp | |
Affiliation | 3H medisolution |
Scientific contact | |
Name | Ochi Kenya |
Address | 8-2,Kyuutaromachi1-chome,Chuo-ku, osaka-shi,Osaka Osaka Japan 541-8564 |
Telephone | +81-6-6263-5670 |
k.ochi@ono-pharma.com | |
Affiliation | ONO PHAMACEUTICAL CO., LTD. |